Skip to content

Docs (opens in a new tab)Pricing Ideas Benchmark

Sign in Sign up

R

RAPP

Rapport Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

NASDAQ · Healthcare · Biotechnology · US

$28.60

+3.74%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsIdeas

Idea

No published Drillr research on RAPP yet.

Ask Drillr about RAPP Browse research →

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Workspace|Docs (opens in a new tab)|Pricing|Research|Methodology|Privacy|Disclaimer|Contact|© 2026 LIL GREBE INC.